Latest Disclosure Compliance News

Sagalio Energy’s shares surged sharply on November 12, prompting ASX to demand clarity on undisclosed information and compliance with disclosure rules.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

Aguia Resources has responded to an ASX price query following a dramatic surge in its share price, confirming no new material exploration results have been received or withheld. The company asserts full compliance with continuous disclosure obligations despite market speculation.

Worley Limited has affirmed its FY25 earnings were consistent with prior guidance and analyst expectations, with only a minor margin outperformance deemed immaterial. The company confirms compliance with ASX continuous disclosure rules following an ASX inquiry.

Ramsay Health Care has clarified that its underlying earnings for FY25 aligned closely with market consensus, despite a significant non-cash impairment impacting statutory profits. The company confirms compliance with ASX disclosure rules amid share price volatility.

RPMGlobal Holdings clarifies the reasons behind withdrawing its FY2025 earnings guidance following the divestment of its Advisory business, providing detailed updates on software segment performance and compliance with ASX disclosure rules.

EVT Limited has responded to ASX inquiries confirming its FY25 earnings were broadly in line with market forecasts, despite a notable post-results share price decline.

AGL Energy has clarified that its FY25 underlying earnings aligned with market forecasts and published guidance, dismissing any material surprises in its financial results. The company also addressed statutory profit volatility and confirmed compliance with ASX disclosure rules.

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

SportsHero Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed price-sensitive information and ongoing compliance with disclosure rules.

Key Petroleum has completed a $152,361 placement, issuing over 3.6 million shares to a sophisticated investor to support merger preparations and working capital needs.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.